Background
Achieving successful commercialization for a drug in the hospital environment was becoming increasingly difficult pre-pandemic. However, the pandemic aggravated this massive challenge to the point when conventional solutions were hardly helping to make meaningful progress. Our client, a leading independent biopharmaceutical company providing a novel life-saving antimicrobial drug had a successful launch which was slowed substantially by the COVID19 developments. This created a critical need for developing an innovative way to win in a hospital setting.
 Â